AstraZeneca

Canada is about to toss more than half of its doses of the Oxford-AstraZeneca COVID-19 vaccine because it couldn't find any takers for it either at home or abroad.

The Canadian government has signed an agreement with pharmaceutical company AstraZeneca to procure 100,000 doses of a COVID−19 antibody therapy that’s still under review by Health Canada.

The leaders of the world’s economic powerhouses on Saturday, October 30, 2021, took part in the first in-person summit since the coronavirus pandemic, with climate change, COVID-19 economic recovery and the global minimum corporate tax rate on the agenda.

The National Advisory Committee on Immunization says people who got the Oxford-AstraZeneca vaccine for the first dose can be offered either Pfizer-BioNTech or Moderna for the second.

Canada's first homegrown vaccine for COVID-19 is showing promising antibody results in hundreds of participants in a Phase 2 trial and could be ready for a final authorization request this summer.

Even at the best of times, mixed messaging is problematic. But introducing it into an information ecosystem that’s rife with bad-faith actors and conspiracy theorists is a recipe for disaster, writes columnist Max Fawcett.

The National Advisory Committee on Immunization says there is now enough "real-world evidence" to show the Oxford-AstraZeneca COVID-19 vaccine is both safe and effective for seniors.

Canada added a single-dose COVID-19 vaccine to its pandemic-fighting arsenal on Friday, approving Johnson & Johnson's product a week after it was authorized in the United States.

Several provinces began expanding their COVID-19 vaccination programs to members of the general population on Monday, March 1, 2021, as new recommendations on the use of the AstraZeneca vaccine suggested it should be targeted at younger Canadians.

Health Canada approved its third COVID-19 vaccine on Friday, authorizing the jab made by AstraZeneca and Oxford University after a lengthy review of clinical trial details.

Canada's vaccine rollout received a boost on Friday, February 26, 2021, with the approval of a third COVID-19 inoculation, giving the country another immunization option at a time when case counts remain nearly 75 per cent higher than they were at the peak of the first wave of the pandemic.

Health Canada has approved the COVID-19 vaccine from AstraZeneca, the third to be given the green light for national use.